STRAN & COMPANY, INC. (SWAG)
Stran & Company Reports $31.2 Million in Revenue and Achieves EBITDA of $1.0 Million for the First Quarter of 2026
Stran & Company Reports $31.2 Million in Revenue and Achieves EBITDA of $1.0 Million for the First Quarter of 2026
📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical